Back to Research
NB
NBY
NovaBay Pharmaceuticals, Inc.
PHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
2.41B
Volume
10.34M
52W High
$19.95
52W Low
$0.46
Open
$9.87
Prev Close
$9.46
Day Range
9.69 - 19.95
About NovaBay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically-proven eyecare, wound care, and skin care products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material, including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease.
Latest News
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga•9/29/2025
NovaBay Pharmaceuticals Issues a Reminder of Important Information Regarding the Pending Special Dividend and Upcoming 2025 Annual Meeting
Benzinga•9/18/2025
Impetigo Drugs Global Strategic Business Report 2024 - Fusidane Drug Segment is Expected to Reach US$883.5 Million by 2030, with a CAGR of a 5.1%
GlobeNewswire Inc.•9/2/2024
NovaBay slashes prices on eyecare products for Amazon Prime Day - Investing.com
Investing.com•7/16/2024
NovaBay reports 9% increase in eyecare revenue in 2024 - Investing.com
Investing.com•7/11/2024
First Phase of Exploration on Foothills Property Confirms Presence of High TiO2 Grades
GlobeNewswire Inc.•6/27/2024
La première phase d’exploration sur la propriété Foothills confirme la présence de fortes teneurs en TiO2
GlobeNewswire Inc.•6/27/2024
NioBay recois une subvention de 500 000 $
GlobeNewswire Inc.•6/25/2024